Sandbox/a: Difference between revisions

	Middle East Respiratory Syndrome Coronavirus Infection Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Middle East Respiratory Syndrome Coronavirus Infection from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Diagnostic Studies
Treatment
Medical Therapy
Contact and Airborne Precautions
Primary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Sandbox/a On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sandbox/a All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sandbox/a
CDC on Sandbox/a
Sandbox/a in the news
Blogs on Sandbox/a
Directions to Hospitals Treating Middle East respiratory syndrome coronavirus infection
Risk calculators and risk factors for Sandbox/a

VisualWikitext

Latest revision as of 18:42, 18 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The symptoms of the middle east respiratory syndrome coronavirus infection include fever, cough, shortness of breath and gatsrointestinal symptoms.

History and Symptoms

Symptom	Percentage
Fever Fever with chills or rigors	98% 87%
Cough Dry Productive	83% 47% 36%
Hemoptysis	17%
Shortnes of breath	72%
Chest Pain	15%
Sore throat	21%
Runny Nose	4%
Abdominal Pain	17%
Nausea	21%
Vomiting	21%
Diarrhoea	26%
Myalgia	32%
Headache	13%

Suspect MERS-CoV infection in case of:

Fever (≥38°C, 100.4°F) and pneumonia or acute respiratory distress syndrome (based on clinical or radiological evidence);

AND EITHER

History of travel from countries in or near the Arabian Peninsula1 within 14 days before symptom onset;

OR

Close contact2 with a symptomatic traveler who developed fever and acute respiratory illness (not necessarily pneumonia) within 14 days after traveling from countries in or near the Arabian Peninsula;

OR

Is a member of a cluster of patients with severe acute respiratory illness (e.g. fever and pneumonia requiring hospitalization) of unknown etiology in which MERS-CoV is being evaluated, in consultation with state and local health departments.

Symptoms

Fever (98%)
Cough (83%)
Shortness of breath (72%)
Gastrointestinal symptoms
- Diarrhea (26%)
- Vomiting (21%)

All but two patients (96%) had one or more chronic medical conditions, including diabetes (68%), hypertension (34%), heart disease (28%), and kidney disease (49%). Thirty-four (72%) had more than one chronic condition. In a retrospective study on 47 patients with MERS-CoV infection, 42 (89%) needed intensive care and 34 (72%) had mechanical ventilation.^[1]

References

↑ Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A; et al. (2013). "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study". Lancet Infect Dis. 13 (9): 752–61. doi:10.1016/S1473-3099(13)70204-4. PMID 23891402.

Template:WH Template:WS

[pmid23891402-1] Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A; et al. (2013). "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study". Lancet Infect Dis. 13 (9): 752–61. doi:10.1016/S1473-3099(13)70204-4. PMID 23891402.

[1]

@@ Line 1: / Line 1: @@
+{{MERS}}
+{{CMG}}
+==Overview==
+The symptoms of the middle east respiratory syndrome coronavirus infection include [[fever]], [[cough]], [[shortness of breath]] and gatsrointestinal symptoms.
+==History and Symptoms==
+{|style="float: right; border: 0px; font-size: 90%; margin: 3px;"
+! style="width: 150px; background: #4479BA"|{{fontcolor|#FFF| '''''Symptom '''''}}
+! style="width: 100px; background: #4479BA"|{{fontcolor|#FFF| '''''Percentage '''''}}
+|-
+|  style="background: #F5F5F5"| Fever <br>&nbsp;&nbsp;&nbsp;Fever with chills or rigors
+|  style="background: #F5F5F5"| 98% <br>&nbsp;&nbsp;&nbsp;87%
+|-
+|  style="background: #F5F5F5"| Cough <br>&nbsp;&nbsp;&nbsp;Dry <br>&nbsp;&nbsp;&nbsp;Productive
+|  style="background: #F5F5F5"|83% <br>&nbsp;&nbsp;&nbsp;47% <br>&nbsp;&nbsp;&nbsp;36%
+|-
+|  style="background: #F5F5F5"|Hemoptysis
+|  style="background: #F5F5F5"|17%
+|-
+|  style="background: #F5F5F5"|Shortnes of breath
+|  style="background: #F5F5F5"|72%
+|-
+|  style="background: #F5F5F5"|Chest Pain
+|  style="background: #F5F5F5"|15%
+|-
+|  style="background: #F5F5F5"|Sore throat
+|  style="background: #F5F5F5"|21%
+|-
+|  style="background: #F5F5F5"| Runny Nose
+|  style="background: #F5F5F5"|4%
+|-
+|  style="background: #F5F5F5"| Abdominal Pain
+|  style="background: #F5F5F5"|17%
+|-
+|  style="background: #F5F5F5"| Nausea
+|  style="background: #F5F5F5"|21%
+|-
+|  style="background: #F5F5F5"| Vomiting
+|  style="background: #F5F5F5"|21%
+|-
+|  style="background: #F5F5F5"| Diarrhoea
+|  style="background: #F5F5F5"|26%
+|-
+|  style="background: #F5F5F5"| Myalgia
+|  style="background: #F5F5F5"|32%
+|-
+|  style="background: #F5F5F5"| Headache
+|  style="background: #F5F5F5"|13%
+|}
+Suspect MERS-CoV infection in case of:<br>
+* Fever (≥38°C, 100.4°F) and pneumonia or acute respiratory distress syndrome (based on clinical or radiological evidence);<br>
+''AND EITHER'' <br>
+* History of travel from countries in or near the Arabian Peninsula1 within 14 days before symptom onset;<br>
+''OR''<br>
+* Close contact2 with a symptomatic traveler who developed fever and acute respiratory illness (not necessarily pneumonia) within 14 days after traveling from countries in or near the Arabian Peninsula;<br>
+''OR''<br>
+* Is a member of a cluster of patients with severe acute respiratory illness (e.g. fever and pneumonia requiring hospitalization) of unknown etiology in which MERS-CoV is being evaluated, in consultation with state and local health departments.
-Middle East Respiratory Syndrome (MERS) is viral respiratory illness first reported in Saudi Arabia in 2012. It is caused by a coronavirus called MERS-CoV. Most people who have been confirmed to have MERS-CoV infection developed severe acute respiratory illness. They had fever, cough, and shortness of breath. About 30% of people confirmed to have MERS-CoV infection have died.<ref name=CDC>{{cite web | title = Middle East Respiratory Syndrome (MERS) | url = http://www.cdc.gov/CORONAVIRUS/MERS/INDEX.HTML }}</ref> Healthcare providers should be prepared to detect patients who should be evaluated for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection; this requires clinical judgment as information on modes of transmission of MERS-CoV and clinical presentation of MERS is limited and continues to evolve.<ref name=CDC2>{{cite web | title = Interim Guidance for Health Professionals | url = http://www.cdc.gov/coronavirus/mers/interim-guidance.html }}</ref>
+===Symptoms===
+* [[Fever]] (98%)
+* [[Cough]] (83%)
+* [[Shortness of breath]] (72%)
+* Gastrointestinal symptoms
+** [[Diarrhea]] (26%)
+** Vomiting (21%)
+All but two patients (96%) had one or more chronic medical conditions, including [[diabetes]] (68%), [[hypertension]] (34%), [[heart disease]] (28%), and [[kidney disease]] (49%). Thirty-four (72%) had more than one chronic condition.  In a retrospective study on 47 patients with MERS-CoV infection, 42 (89%) needed intensive care and 34 (72%) had mechanical ventilation.<ref name="pmid23891402">{{cite journal| author=Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A et al.| title=Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. | journal=Lancet Infect Dis | year= 2013 | volume= 13 | issue= 9 | pages= 752-61 | pmid=23891402 | doi=10.1016/S1473-3099(13)70204-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23891402  }} </ref>
+==References==
+{{Reflist|2}}
-==References==
+{{WH}}
+{{WS}}
+[[category:disease]]
-{{reflist|2}}
+[[category:virology]]
+[[Category:Up-To-Date]]